Diabetes clinical studies are an important part of the research process. New drugs, treatment methods, and biological processes are often tested in lab animals in order for researchers to investigate and modify their hypotheses and methods. Often research moves into clinical trials on humans, an essential step for new drugs. Participants are voluntary and are selected through distinct parameters determined by the researchers, in order to provide a view of a select portion of the population. Trials are often “randomized”,  “blind”, or “masked”. Blind or masked trials are comparisons of one or more treatments sometimes involving a placebo. Participants are not told to which group they are assigned making the study randomized in order to eliminate bias. Participants are always told when there is a placebo involved. To learn more about national and state level trials, research budgets, statistics and historically ground-breaking diabetes trials, the Center for Disease Control (CDC) …